MGMT and central nervous system cancer: 1p19q codeletion is a combination of loss of the short arm chromosome 1 (1p) and the long arm of chromosome 19 (19q), 1p19q codeletion, MGMT promoter methylation and/or IDH1 mutation signified a better prognosis for glioma patients30.